Lux, M. P., Wöckel, A., Benedict, A., Buchholz, S., Kreif, N., Harbeck, N., . . . Schneeweiss, A. (2010). Cost-effectiveness analysis of anastrozole versus tamoxifen in adjuvant therapy for early-stage breast cancer: A health-economic analysis based on the 100-month analysis of the ATAC trial and the German health system. Oncology research and treatment, 33(4), . https://doi.org/10.1159/000286233
Chicago-Zitierstil (17. Ausg.)Lux, Michael Patrick, et al. "Cost-effectiveness Analysis of Anastrozole Versus Tamoxifen in Adjuvant Therapy for Early-stage Breast Cancer: A Health-economic Analysis Based on the 100-month Analysis of the ATAC Trial and the German Health System." Oncology Research and Treatment 33, no. 4 (2010). https://doi.org/10.1159/000286233.
MLA-Zitierstil (9. Ausg.)Lux, Michael Patrick, et al. "Cost-effectiveness Analysis of Anastrozole Versus Tamoxifen in Adjuvant Therapy for Early-stage Breast Cancer: A Health-economic Analysis Based on the 100-month Analysis of the ATAC Trial and the German Health System." Oncology Research and Treatment, vol. 33, no. 4, 2010, https://doi.org/10.1159/000286233.